TY - JOUR
T1 - Reengineering neurotechnology
T2 - placing patients first
AU - Ploner, Markus
AU - Buyx, Alena
AU - Gempt, Jens
AU - Gjorgjieva, Julijana
AU - Müller, Ruth
AU - Priller, Josef
AU - Rückert, Daniel
AU - Wolfrum, Bernhard
AU - Jacob, Simon N.
N1 - Publisher Copyright:
© Springer Nature America, Inc. 2023.
PY - 2023/1
Y1 - 2023/1
N2 - Neurotechnologies that measure and modulate brain activity have not yet reached widespread clinical relevance. To accelerate translation into patient care, we propose three strategic adjustments in neurotechnology research — to consider the scope, scalability and stakeholders.
AB - Neurotechnologies that measure and modulate brain activity have not yet reached widespread clinical relevance. To accelerate translation into patient care, we propose three strategic adjustments in neurotechnology research — to consider the scope, scalability and stakeholders.
UR - http://www.scopus.com/inward/record.url?scp=85163706051&partnerID=8YFLogxK
U2 - 10.1038/s44220-022-00011-x
DO - 10.1038/s44220-022-00011-x
M3 - Comment/debate
AN - SCOPUS:85163706051
SN - 2731-6076
VL - 1
SP - 5
EP - 7
JO - Nature Mental Health
JF - Nature Mental Health
IS - 1
ER -